Health Condition 1: J309- Allergic rhinitis, unspecified
Conditions
Interventions
Intervention1: Lauq Rumman: Patients will be provided the study drug Lauq Rumman 10gm orally thrice daily with lukewarm water for 21 days.
Control Intervention1: NIL: NIL
Sponsors
State Unani Medical College and HAHRDM Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age between 18 50 years 2. Both gender 3. Symptoms persisted for more than 4 days per week or more than 4 weeks per year and at least one of the following rhinitis associated conditions: nasal congestion, rhinorrhea, sneezing and nasal itching 4. Patients who will give consent and able to do follow up
Exclusion criteria
Exclusion criteria: 1. Patients suffering from systemic illness like Hypertension, DM, Malignancy, Liver or Kidney dysfunction 2. Patients suffering from congenital nasal abnormalities like nasal dermoid cysts, congenital midline nasal masses, Deviated Nasal Septum, Atrophic rhinitis, Sinusitis, Hypertrophic turbinates, Adenoidal hypertrophy, foreign bodies or Asthma 3. Patients below 18 and above 50 years 4. Patients with past history of nose surgery 5. Patients had received systematically administered corticosteroids, antihistamines, decongestants or CAM therapy within 02 weeks prior to enrolment 6. Pregnant and lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Changes in Total Nasal Symptom Score (TNSS) and 2. Allergic Rhinitis Control Test (ARCT)Timepoint: Day 7, 14 and 21. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Improvement in Mini Rhino conjunctivitis Quality of Life Questionnaire (Mini RQLQ) 2. AEC( Absolute Eosinophilc Count )Timepoint: Day 7, 14 and 21. | — |
Countries
India
Contacts
Public ContactDr Usamah Ahmad
State Unani Medical College, Himmatganj, Prayagraj, Uttar Pradesh.
Outcome results
None listed